Improving Quality and Safety in the Endoscopy Unit (Virtual) | August 2023-Guideline

Guideline_ASGE antithrombotics

Pdf Summary

Guidelines for managing antithrombotic therapy during GI endoscopy, considering bleeding risk and thromboembolic events. Continuing anticoagulants during endoscopy is safe within a specific INR range. Risk/benefit of interrupting therapy should be assessed. Recommendations for specific agents like warfarin, ASA, and thienopyridines. Delay high-risk procedures for post-ACS and intracoronary stent patients until completion of minimum antithrombotic therapy. Bridge therapy for high-risk procedures. Resumption of therapy after GI bleeding control is crucial.

Keywords

antithrombotic therapy

GI endoscopy

bleeding risk

thromboembolic events

anticoagulants

INR range

interrupting therapy

warfarin

ASA

thienopyridines